October 28, 2015
The awarding ceremony of Prix Galien U.S.A. was held at the American Museum of Natural History and the prizes were awarded as following:
- ibrutinib (IMBRUVICA®, Janssen Biotech, Inc. & Pharmacyclics LLC and Abbvie)
- nivolumab (OPDIVO®, Bristol-Myers Squibb)
- pembrolizumab (KEYTRUDA®, Merck & Co)
- T2Candida Panel – T2 Biosystems, Inc.
For more information please contact Mr. Michael Francoeur Makovsky, firstname.lastname@example.org